Related Experiment Video
Updated: Jul 15, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Proteasome inhibitors sensitize human vascular smooth muscle cells to Fas (CD95)-mediated death
1Department of Pathology, University of Washington, Seattle, Washington 98195, USA. koanhoi@u.washington.edu
Abstract:
It was investigated whether proteasome activity was implicated in susceptibility of human vascular smooth muscle cells (VSMCs) to Fas-mediated death. Human fetal aorta smooth muscle cells were treated with agonistic anti-Fas antibody (CH11) and proteasome inhibitors (MG115 or MG132) and then cell death was determined by morphology, viability, and DNA fragmentation. The present study reports that: (a) crosslinking of Fas receptor with anti-Fas antibody in the presence of proteasome inhibitor-induced death and DNA degradation in human VSMCs that were blocked by caspases inhibitor z-DEVD.fmk; (b) cotreatment with anti-Fas antibody and proteasome inhibitor activated caspase-3; (c) proteasome inhibitors did not influence expression of procaspase-8, procaspase-3, c-FLIP, and Bcl-2; and (d) proteasome inhibitors up-regulated Fas and FADD. The data indicate that proteasome activity is important in survival of VSMCs and provide the first evidence that proteasome is involved in Fas signal transduction. The present study proposes novel mechanism(s) by which VSMCs become susceptible to FasL.
Insights
Proteasome activity is crucial for vascular smooth muscle cell (VSMC) survival. Inhibiting proteasomes enhances VSMC susceptibility to Fas-mediated death by influencing Fas signaling pathways.
Area of Science:
- Cell Biology
- Molecular Biology
- Cardiovascular Research
Background:
- Vascular smooth muscle cells (VSMCs) play a critical role in cardiovascular health.
- Fas-mediated apoptosis is a key pathway regulating cell death.
- The role of proteasome activity in VSMC susceptibility to Fas-mediated death remains unclear.
Purpose of the Study:
- To investigate the role of proteasome activity in human VSMC susceptibility to Fas-mediated apoptosis.
- To elucidate the mechanisms by which proteasome inhibition affects Fas signaling in VSMCs.
Main Methods:
- Human fetal aorta smooth muscle cells were treated with agonistic anti-Fas antibody (CH11) and proteasome inhibitors (MG115 or MG132).
- Cell death was assessed using morphology, viability assays, and DNA fragmentation analysis.
- Western blotting was used to determine the expression levels of key proteins involved in apoptosis signaling.
Main Results:
- Proteasome inhibition, in conjunction with anti-Fas antibody, induced VSMC death and DNA degradation, which was blocked by a caspase inhibitor.
- Co-treatment with anti-Fas antibody and proteasome inhibitors activated caspase-3.
- Proteasome inhibitors did not alter the expression of procaspase-8, procaspase-3, c-FLIP, or Bcl-2, but upregulated Fas and FADD expression.
Conclusions:
- Proteasome activity is essential for VSMC survival.
- This study provides the first evidence linking proteasome function to Fas signal transduction in VSMCs.
- Novel mechanisms are proposed for VSMC susceptibility to Fas ligand-induced apoptosis under proteasome inhibition.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy

